Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2003
03/12/2003CN1401389A Hepatitis B vaccine preparation
03/12/2003CN1401328A Epidemic meningitis polyose-protein binding vaccine
03/12/2003CN1102855C Immunotherapeutic composition
03/11/2003USRE38028 Administering P. Multocida, P. Haemolytica or H. somnus, a recombinant construct comprising DNA segment and plasmid PBB192 to form transformants
03/11/2003US6531587 Retrovirus from the HIV group and its use
03/11/2003US6531580 Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
03/11/2003US6531574 T-lymphotrophic virus
03/11/2003US6531500 Treating a skin condition or disease characterized by ulceration, inflammation, or blistering by administering an oil-in-water emulsion comprising: (a) allantoin; and (b) an emulsifier system including beeswax and an anionic emulsifier
03/11/2003US6531451 Isolated antigenic peptide consisting of specified amino acid sequence
03/11/2003US6531315 Stimulating or expanding T cells (which are specific for cells expressing tumor proteins) by contacting them with given amino acid sequence
03/11/2003US6531313 Invasive bacterial vectors for expressing alphavirus replicons
03/11/2003US6531307 Capable of activating a compound with little or no toxicity into an active product; use in treating viral diseases, cancer, and genetic disorders
03/11/2003US6531276 Using probes to determine duplex formation; use in diagnostic, prophylactic, and therapeutic applications
03/11/2003US6531156 Aqueous solven encapsulation method, apparatus and microcapsules
03/11/2003US6531138 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypetides and peptides in the diagnostic of tuberculosis
03/11/2003US6531137 Retrovirus from the HIV group and its use
03/11/2003US6531131 Neisseria meningitidis lipooligosaccharide from which at least one primary O-linked fatty acid has been removed to detoxify it, covalently linked to immunogenic carrier
03/11/2003US6531130 Treatment of demyelinating autoimmune disease with ordered peptides
03/11/2003US6531129 Heparanase specific molecular probes and their use in research and medical applications
03/11/2003US6531127 Useful for diagnostic purposes for identifying specific antibodies against human papillomavirus 16 E1 or E2 protein, which contains polypeptides with specific amino acid sequece
03/11/2003US6531123 Safer, yet permit increased efficiency of packaging the recombinant viral genome and increased long-term gene expression
03/11/2003CA2138778C Fusobacterium necrophorum leukotoxoid vaccine
03/11/2003CA2109085C Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
03/10/2003CA2369250A1 Novel anti-viral and anti-proliferative agents derived from stat1 transcription factor
03/06/2003WO2003019198A2 Methods relating to treatment of atherosclerosis
03/06/2003WO2003019196A2 Diagnosis and treatment of atherosclerosis
03/06/2003WO2003019136A2 Methods for inhibiting angiogenesis
03/06/2003WO2003018811A1 Gene of novel corynebacterium diphtheriae antigen
03/06/2003WO2003018768A2 Transmembrane protein differentially expressed in cancer
03/06/2003WO2003018635A1 Human cdr-grafted antibodies and antibody fragments thereof
03/06/2003WO2003018632A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
03/06/2003WO2003018630A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003WO2003018623A2 Papillomavirus proteins and pharmaceutical compositions
03/06/2003WO2003018611A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003WO2003018064A2 Lipophilic drug compositions
03/06/2003WO2003018056A1 Stabilized preparations containing antibody
03/06/2003WO2003018055A1 Vaccine using papilloma virus e proteins delivered by viral vector
03/06/2003WO2003018054A1 Helicobacter pylori vaccination
03/06/2003WO2003018053A1 Vaccine against mycobacterial-induced diseases
03/06/2003WO2003018052A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003WO2003018051A1 Anti-fungal composition
03/06/2003WO2003018039A1 Pharmaceutical ingredient for medical treatment and preventing of cancer
03/06/2003WO2003017992A2 Means for treatment of atherosclerosis
03/06/2003WO2003017944A2 Gpi-anchored cytokines
03/06/2003WO2003017941A2 Flexible applicator for applying oil-in-water emulsion with improved stability
03/06/2003WO2003017940A2 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
03/06/2003WO2003017935A2 Human antibodies specific for interleukin 15 (il-15)
03/06/2003WO2003017933A2 Method and apparatus using idstm for multi-agent therapy
03/06/2003WO2003017919A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
03/06/2003WO2003017780A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
03/06/2003WO2003017755A2 Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
03/06/2003WO2003000729A3 Secreted polypeptide and their use in the treatment of bone disorders
03/06/2003WO2002099097A8 Novel compounds for chemiluminescense procedures
03/06/2003WO2002088319A3 Mini-adenoviral vector and methods of using same
03/06/2003WO2002088178A8 Antigens of group b streptococcus and corresponding dna fragments
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002085945A3 Vhh single heavy chain antibody and a method for its preparation in a mammal
03/06/2003WO2002085447A3 Microprojection array having a beneficial agent containing coating
03/06/2003WO2002085446A3 Microprojection array immunization patch and method
03/06/2003WO2002083068A8 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
03/06/2003WO2002081709A3 Modified hpv e6 and e7 genes and proteins useful for vaccination
03/06/2003WO2002074243A9 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
03/06/2003WO2002066516A3 Antibodies that bind both bcma and taci
03/06/2003WO2002064731A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/06/2003WO2002062959A3 Hepatitis b virus treatment
03/06/2003WO2002062845A3 Adhesion molecules
03/06/2003WO2002060929A3 Polymer conjugates of neublastin and methods of using same
03/06/2003WO2002059302A3 Regulation of human serotonin-like g protein-coupled receptor
03/06/2003WO2002059264A3 Specific human antibodies for selective cancer therapy
03/06/2003WO2002055106A3 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
03/06/2003WO2002051994A8 Polypeptides
03/06/2003WO2002045742A8 Lipoteichoic acid immunogenic compositions and methods of making and using thereof
03/06/2003WO2002043661B1 Recombinant anti-cd30 antibodies and uses thereof
03/06/2003WO2002031151A3 Lipocalins
03/06/2003WO2002028481A3 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
03/06/2003WO2002022080A9 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
03/06/2003WO2002016421A3 Altered ospa of borrelia burgdorferi
03/06/2003WO2002012325A3 Suppressor gene
03/06/2003WO2002012281A9 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
03/06/2003WO2002010401A3 18431 and 32374, human protein kinase family members and uses therefor
03/06/2003WO2002004018A8 Mid-life vaccine and methods for boosting anti-mycobacterial immunity
03/06/2003WO2001098361A9 Agonist anti-trk-c monoclonal antibodies
03/06/2003WO2001096394A3 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders
03/06/2003WO2001092525A8 Compositions and methods for the therapy and diagnosis of lung cancer
03/06/2003WO2001080880A8 Apoptotic agents
03/06/2003WO2001077146A3 Compounds and methods for modulating endothelial cell adhesion
03/06/2003WO2001074900A9 Nuclear factor kb inducing factor
03/06/2003WO2001068103A9 Treatment of herpes infection using immunomodulatory polynucleotide sequences
03/06/2003WO2001066741A9 Kcnb: a novel potassium channel protein
03/06/2003WO2001062924A9 Human g protein-coupled receptors
03/06/2003WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
03/06/2003US20030046714 Anti-neovasculature preparations for cancer
03/06/2003US20030045704 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030045702 Secreted Chlamydia polypeptides and method for identifying such polypeptides by their secretion by a type III secretion pathway of a gram-negative bacteria
03/06/2003US20030045691 Reshaped human anti-hm 1.24 antibody
03/06/2003US20030045690 Having a mean diameter of 200-2000 nm, obtained by solidification from a mixture comprising fibrinogen, thrombin and Factor XIII in an water in oil emulsion
03/06/2003US20030045682 Antibodies immunospecific for STEAP1
03/06/2003US20030045676 Peptides, antibodies, vaccines & uses thereof
03/06/2003US20030045579 Compounds and compositions for delivering active agents
03/06/2003US20030045499 Intradermally administering an expression construct of a self gene under the control of a promoter whereby said self gene product is expressed by dendritic cells to stimulate anti-self gene product response
1 ... 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 ... 1823